Interview with the Innovators

Interview with the Innovators

Video Library | September 24, 2021
The last 10 to 15 years has seen important advances in the management of advanced renal-cell cancer. Laura Wood, RN, MSN, OCN; Megan Price, MSN, APRN, FNP-C; and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss how real-world efficacy and safety data influence the conversations they have with their patients with advanced renal-cell carcinoma regarding treatment options.
Video Library | September 13, 2021
Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss their approach to conversations with patients and families regarding first-line therapy for advanced renal-cell carcinoma. They also describe what resources they share with patients to help them after the initial consultation.
Video Library | August 13, 2021
Maintaining quality of life for cancer patients means different things to different cancer patients. However, the conversation starts with helping patients manage their expectations regarding their therapy and how it will impact their quality of life. Please join Laura Wood, RN, MSN, OCN, Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, as they examine the many ways that they collaborate with their oncology team colleagues to assess and review how an individual patient’s treatment regimen is influencing that patient’s quality of life.
Video Library | July 27, 2021
The practice of using combinations of drugs in chemotherapy is not new and continues to evolve to include immune checkpoint inhibitors. Drug combinations can be more effective than single-agent therapy and may also reduce the risk of developing resistance. However, combining multiple drugs may increase the risk of drug interactions. Please join Laura Wood, RN, MSN, OCN, Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, as they discuss how they have a conversation with their patients about the benefits and risks of using drug combinations in anticancer therapy.
Video Library | July 19, 2021
Although chemotherapy is effective in combating cancer, its full benefits are often not realized because many patients do not take their medications as prescribed. There are many factors that contribute to poor medication adherence, including communication barriers, adverse events, and factors that are related to the therapy, such as prescription of complex drug regimens. Because barriers to medication adherence are complex and varied, solutions to improve adherence must also be multifactorial. Laura Wood, RN, MSN, OCN, Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss their best practices to help patients adhere to their chemotherapy regimens.

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country